MedPath
NMPA Approval

Molnupiravir Capsules

国药准字HJ20220097

December 29, 2022

Drug Information

莫诺拉韦胶囊

利卓瑞

胶囊剂

0.2g

化学药品

December 29, 2022

December 28, 2027

Company Information

Applicant Company

120 MOORGATE, LONDON, EC2M 6UR, UNITED KINGDOM

Manufacturing Company

patheon incorporated

111 CONSUMERS DRIVE, WHITBY, L1N 5Z5, CANADA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

莫诺拉韦胶囊 - NMPA 批准文号 | MedPath